Related by context. All words. (Click for frequent words.) 79 Prospective Randomized 77 Overactive Bladder 76 Subgroup Analysis 75 Carotid Stenting 75 Hepatocellular Carcinoma 75 See CLINICAL PHARMACOLOGY 75 Elderly Patients 75 Ischemic Stroke 74 Heart Failure Patients 74 Patients Treated With 74 Metastatic Prostate Cancer 74 Ischemic 74 Acute Ischemic Stroke 74 Rheumatoid Arthritis Patients 73 Minimally Invasive Treatment 73 Severe Sepsis 73 Surgical Treatment 73 Patients Undergoing 73 Secondary Hyperparathyroidism 73 Complicated Skin 73 Relapsing Multiple Sclerosis 73 Acute Decompensated Heart Failure 73 Clinical Outcome 73 Benign Prostatic Hyperplasia 73 Treating Chronic 73 Adjuvant Treatment 73 Juvenile Idiopathic Arthritis 73 Renal Cell Carcinoma 73 Adjunctive 73 Improves Survival 73 Meets Primary Endpoint 73 Oral Fingolimod 73 Venous Thromboembolism 73 Improves Outcomes 72 Allergic Rhinitis 72 Investigational Treatment 72 Inhaled Corticosteroids 72 Relapsed Refractory 72 Controlled Trial 72 Atypical Hemolytic Uremic Syndrome 72 Advanced Melanoma 72 Patients Receiving 72 Gastric Cancer 72 ACE Inhibitors 72 Acute Coronary Syndromes 72 Invasive Breast Cancer 72 Cardiac Resynchronization Therapy 72 Breast Cancer Recurrence 72 Pediatric Patients 72 Ranolazine 72 Diabetic Patients 72 Randomized Controlled Trials 72 Treatment Resistant 72 Beta Blocker 72 Demonstrates Positive 72 Subtypes 72 Pulmonary Arterial Hypertension 72 Chronic HCV 72 Chronic Sinusitis 72 Prolongs Survival 72 J Am Coll 72 Acute Myocardial Infarction 72 Clinical Trial Results 72 Reduces Mortality 71 Lupus Nephritis 71 Myelodysplastic Syndromes 71 Patients Suffering 71 Advanced Renal Cell 71 Phase 2b Clinical Trial 71 Intracerebral Hemorrhage 71 Coronary Angiography 71 Shows Promise Against 71 Combination Treatment 71 Thiazolidinediones 71 Slows Progression 71 Knee Osteoarthritis 71 Suicidality 71 Neovascular Age Related Macular 71 dual endothelin receptor antagonist 71 Renal Artery 71 Chronic Hepatitis B 71 Phase III Clinical Trial 71 Renal Impairment 71 Benign Prostatic Hyperplasia BPH 71 Generalized Anxiety Disorder 71 Newly Diagnosed Multiple Myeloma 71 Arrhythmias 71 Severe Asthma 71 Recurrent Breast Cancer 71 Non Alcoholic Fatty 71 Bone Metastases 71 Thromboembolic 71 Improve Survival 71 Adjunctive Therapy 71 NAVISTAR R 71 Left Ventricular 71 Hyperlipidemia 71 Atopic Dermatitis 71 hyperphenylalaninemia HPA due 71 Immune Mediated 71 Antiplatelet 71 Pooled Analysis 71 metastatic malignant 71 Prophylactic Treatment 71 Urinary Incontinence 71 Randomized Controlled Trial 71 Cognitive Impairment 71 Meta Analysis 71 Phase IIb Trial 71 Fracture Risk 71 Preterm Delivery 71 Inflammatory Markers 71 Sleep Disturbances 71 Treating Heart Failure 71 Postmenopausal Women 71 Hypercholesterolemia 71 Prognostic Significance 71 Fondaparinux 71 Long Term Efficacy 71 Cutaneous T 71 Diabetic Foot Ulcer 71 Appears Safe 70 Chronic Hepatitis C 70 Unstable Angina 70 Coronary Artery Bypass Graft 70 myelodysplastic myeloproliferative diseases 70 Diabetic Neuropathy 70 Soft Tissue Sarcoma 70 Adjuvant Chemotherapy 70 Acute Heart Failure 70 Relapsing Remitting Multiple Sclerosis 70 Hypertensive Patients 70 Orthostatic Hypotension 70 Uterine Fibroids 70 FDA Approvals 70 Controlled Study 70 Novel Treatments 70 Myocardial Ischemia 70 Radiofrequency Ablation 70 Patients Treated 70 Primary Hypercholesterolemia 70 Peptic Ulcer 70 Differential Diagnosis 70 Chronic Myeloid Leukemia 70 Node Positive 70 Neuroendocrine Tumors 70 Disease Progression 70 Liver Failure 70 Cardiovascular Events 70 Novel Oral 70 Plaque Psoriasis 70 Osteoarthritis Patients 70 Peripheral Arterial 70 Malignant Melanoma 70 Infarct 70 Parenteral Nutrition 70 Hormone Receptor Positive 70 Intracerebral 70 Major Depressive Disorder 70 Hormone Refractory Prostate Cancer 70 Clinical Efficacy 70 Enlarged Prostate 70 See WARNINGS 70 Study Evaluating 70 Iron Overload 70 Resistant Hypertension 70 Stress Urinary Incontinence 70 Randomized Study 70 Bronchiectasis 70 Panic Disorder 70 Breast Cancer Treatment 70 Nesiritide 70 Cardiotoxicity 70 Hemodialysis Patients 70 Hospitalized Patients 70 Treated Patients 70 Uterine Fibroid Embolization 70 Infarction 70 Lowers Risk 70 chronic eosinophilic leukemia 70 Treatment Shows Promise 70 Insulin Sensitivity 70 Fabry Disease 69 Is Well Tolerated 69 Prognostic Value 69 #-# Full Text 69 Skeletal Muscle 69 Initiate Clinical Trial 69 Acute Renal Failure 69 Autoimmune Diseases 69 Nebulized 69 Premature Infants 69 Bosutinib 69 ST Elevation Myocardial 69 Pivotal Trial 69 Drug Prevents 69 Drug Candidate 69 Heart Transplant Recipients 69 Irritable Bowel 69 ANN INTERN MED 69 Cognitive Deficits 69 Monotherapy 69 Depressive Symptoms 69 Previously Treated 69 CLINICAL PHARMACOLOGY 69 Initiates Clinical Trial 69 Diastolic Heart Failure 69 Cardiovascular Outcomes 69 ST Segment Elevation 69 Clinical Evaluation 69 Invasive Fungal Infections 69 Hospital Acquired Pneumonia 69 Multicenter Study 69 Demonstrates Significant 69 Systematic Review 69 Thromboembolism 69 chronic thromboembolic pulmonary 69 Anticoagulation 69 Antitumor Activity 69 Sipuleucel T 69 Laryngeal Cancer 69 Polyneuropathy 69 Catheter Ablation 69 Degenerative Disc Disease 69 Female Stress Urinary 69 Metabolic Disorder 69 Minimally Invasive Procedure 69 Non Invasive Treatment 69 Pegylated Liposomal Doxorubicin 69 Diabetic Macular Edema 69 Prostate Cancer Treatment 69 Advanced Prostate Cancer 69 Systemic Lupus Erythematosus SLE 69 Idiopathic Pulmonary Fibrosis 69 Systemic Sclerosis 69 Valvular Heart Disease 69 Phase 2b Trial 69 Bare Metal Stent 69 Fungal Infections 69 Chronic Renal Failure 69 CT Angiography 69 Breast Density 69 Bone Fractures 69 Arterial Disease 69 TNF Tumor Necrosis Factor 69 Schizophrenia Treatment 69 Phase III Trial 69 Bipolar Depression 69 Slow Progression 69 Chemoradiation 69 Improved Survival 69 Malignancies 69 Insulin Resistance 69 Renal Insufficiency 69 Antiviral Therapy 69 Survival Benefit 69 Mouse Model 69 Prostate Cancer Patients 69 External Beam 69 Demonstrates Sustained 69 Combo Therapy 69 Less Invasive 69 Smoking Linked 69 Metastatic Colorectal Cancer 69 Treatment Reduces 69 Pivotal Study 69 Lymphocytic 69 Lung Cancer Survival 69 Bipolar Mania 69 Prostatic 69 Surgical Procedures 69 Venous Thrombosis 69 Chronic Insomnia 69 Emerging Therapies 69 Postmenopausal 69 Patient Outcomes 69 Cognitive Function 69 Coronary Arteries 69 Valvular 68 Adenoma 68 Phase IIb Clinical Trial 68 Tyrosine Kinase Inhibitor 68 Shows Efficacy 68 Mycophenolate Mofetil 68 Gene Linked 68 Kidney Function 68 Percutaneous Transluminal Coronary Angioplasty 68 Implantable Cardioverter Defibrillator 68 Autoimmune Disease 68 Delayed Graft Function 68 Acute Coronary Syndromes ACS 68 Drug Shows Promise 68 Breast Ultrasound 68 Completes Enrollment 68 Recurrent Stroke 68 Proves Effective 68 Non Alcoholic Steatohepatitis 68 Stent Thrombosis 68 Plus Ribavirin 68 Progressive Multifocal Leukoencephalopathy 68 Diabetic Neuropathic Pain 68 II Clinical Trial 68 Chronic Constipation 68 Diabetic Nephropathy 68 Gastrointestinal Stromal Tumors 68 Premenopausal Women 68 Clinical Trial Evaluating 68 Randomized Evaluation 68 Intravenous Formulation 68 Nocturia 68 Levels Linked 68 Advanced Heart Failure 68 overactive bladder syndrome 68 Localized Prostate Cancer 68 Naive Patients 68 Statin Therapy 68 Glatiramer Acetate 68 Randomized Trials 68 Mitral Regurgitation 68 Free Full Text 68 Critically Ill Patients 68 Replacement Therapy 68 Guideline Update 68 Asthma COPD 68 Pelvic Organ Prolapse 68 Phase 2b Study 68 Sudden Cardiac Death 68 Patency 68 myocardial infarction ventricular fibrillation 68 Inflammatory Arthritis 68 Prognostic Factors 68 Congestive Heart Failure 68 Heterozygous Familial Hypercholesterolemia 68 Low Dose 68 Intracranial Aneurysms 68 Newly Diagnosed 68 Services #:#-#,# Abstract 68 Endometrial Cancer 68 Aortic Valve 68 Rheumatoid Arthritis RA 68 venous thromboembolic disease 68 Ischaemic 68 Comorbidities 68 Hepatic 68 Myeloma Patients 68 Adjuvant Therapy 68 Aneurysm Repair 68 Colorectal Adenomas 68 Efficacious 68 Unresectable 68 Relapsed Multiple Myeloma 68 Catheter Associated 68 Renal dysfunction 68 Bivalirudin 68 Phase IIa Clinical Trial 68 Single Dose 68 Autologous Stem Cell Transplantation 68 Nonalcoholic Steatohepatitis 68 J Am Acad 68 Nilotinib 68 Randomized Double Blind 68 Improve Outcomes 68 Kidney Transplant Patients 68 Hip Fractures 68 Septic Shock 68 Multicenter Randomized Double 68 Circulatory Support 68 leiomyomas 68 Oral Mucositis 68 Effective Treatments 68 Myelodysplastic Syndrome MDS 68 ARIXTRA R 68 Prostate Biopsy 68 Pharmacologic 68 Anthracycline 68 Polycystic Ovary Syndrome 68 Symptom Relief 68 Skin Lesions 68 Phase 2a Clinical Trial 68 Therapy Improves 68 Unfractionated Heparin 68 Pneumococcal Vaccine 68 Paroxysmal 68 Treatment Naive Patients 68 Occlusive Disease 68 antiarrhythmic drug 68 Systolic Hypertension 68 Psychiatric Disorders 68 Multicenter 68 Combination REOLYSIN R 68 Gastrointestinal Disorders 68 HER2 Positive 68 Effectively Treats 68 Gene Mutation 68 Lamotrigine 68 Obesity Linked 68 Prolongs Life 68 FOLOTYN ® 68 AA Amyloidosis 68 Prospective Multicenter 68 Renal Function 68 Decompensated Heart Failure 68 Castration Resistant Prostate Cancer 68 Atrial 68 Bazedoxifene 68 Successfully Treats 68 Growth Hormone Deficiency 68 induce orthostatic hypotension 68 chronic immune thrombocytopenic 68 Rhinosinusitis 68 Hepatitis C Virus 68 Tumor Response 68 Randomized Clinical Trial 68 Metastatic Melanoma 68 Brain Metastases 68 atypical Hemolytic Uremic Syndrome 68 Intravitreal 68 Pharmacokinetic Study 68 Eluting Stent 68 Obstructive Sleep Apnea 67 Acute Stroke 67 Investigational Agent 67 systolic hypertension 67 Follicular Lymphoma 67 Nonalcoholic Fatty Liver Disease 67 Migraine Headaches 67 Often Misdiagnosed 67 Clinical Practice Guideline 67 Tiotropium 67 FDA Okays 67 Serious Infections 67 Proven Effective 67 Stenosis 67 Postmenopausal Osteoporosis 67 Portal Hypertension 67 Post Operative 67 Pulmonary Artery 67 Int J Radiat Oncol 67 Immunotherapeutic 67 Teva Provides Update 67 Double Blind Randomized 67 Atherosclerotic 67 Bucindolol 67 Drug Eluting Stents 67 Natalizumab 67 Blepharospasm 67 Urinary Tract Infections 67 Atomoxetine 67 Therapy Shows Promise 67 Demonstrates Efficacy 67 Immunosuppressant 67 Juvenile Idiopathic Arthritis JIA 67 Inhaled Nitric Oxide 67 Estrogen Receptor 67 Metastatic Renal Cell Carcinoma 67 Shows Promising 67 progressive dyspnea 67 Colorectal Cancer Patients 67 Infected Patients 67 Chronic Myelogenous Leukemia 67 Chronic Bronchitis 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 HER2 Positive Breast Cancer 67 Lubiprostone 67 Radiofrequency Ablation RFA 67 Advanced Pancreatic Cancer 67 Cardiol 67 cytomegalovirus infection 67 Predict Risk 67 Investigational Compound 67 Etanercept 67 antiplatelet medications 67 Diabetes Hypertension 67 Chronic Pelvic Pain 67 Obese Patients 67 Hormone Therapy 67 Randomized Double blind 67 Combination Therapy 67 Ventricular Tachycardia 67 Trial Evaluating 67 Neoadjuvant Chemotherapy 67 Multiple Myeloma Patients 67 Cilostazol 67 Progenitor Cells 67 Chronic Liver Disease 67 TNF Blockers 67 Ovarian Cancers 67 Female Sexual Arousal 67 Intravascular 67 Pharmacokinetics PK 67 Left Ventricular Hypertrophy 67 Genetic Variation 67 Leukemias 67 Pivotal Phase III 67 atherothrombotic disease 67 Lung Cancer Patients 67 Stent Implantation 67 Cardiovascular Mortality 67 ORLive Presents 67 Prevent Stroke 67 Completes Patient Enrollment 67 NIDDM 67 JAK2 Inhibitor 67 Risk Stratification 67 Osteoporosis Drugs 67 aldosterone antagonists 67 Crit Rev 67 Hypertriglyceridemia 67 Placebo Controlled Study 67 Phase Ib Clinical Trial 67 Nonsurgical 67 Androgen Deprivation Therapy 67 Sleep Disordered Breathing 67 Total Knee Replacement 67 Increased Mortality 67 Pivotal Clinical Trial 67 Spinal Fusion 67 Phase 2a Trial 67 Stent Restenosis 67 EnteroMedics proprietary neuroblocking technology 67 Community Acquired Pneumonia 67 Genes Linked 67 Shows Statistically Significant 67 Oral Formulation 67 Mg Usa 67 Left Atrial 67 Thrombotic 67 Dual Antiplatelet Therapy 67 Myocardial Infarction Study 67 Suicidal Behavior 67 Neoplasms 67 Refractory Hodgkin Lymphoma 67 Initiates Phase III 67 Treatment Outcome 67 Treatment Naive 67 Transdermal Patch 67 Treating Depression 67 Stem Cell Treatment 67 HeFH 67 rheumatoid arthritis osteoarthritis ankylosing 67 Hormone Replacement 67 Novel Inhibitor 67 complement inhibitor eculizumab 67 MR Angiography 67 JAK Inhibitor 67 thetreatment 67 Interferon Beta 67 Osteoporosis Treatment 67 Previously Untreated 67 Schizoaffective Disorder 67 Prevent Heart 67 Fecal Incontinence 67 Cardiac Resynchronization 67 vWD 67 Clostridium difficile Infection 67 Protein Linked 67 Bronchopulmonary Dysplasia 67 Myelofibrosis 67 FDA APPROVES 67 Refractory Angina 67 Angiographic 67 Ventricular Arrhythmias 67 Efficacy Trial 67 Myocardial Perfusion Imaging 67 Hyperkalemia 67 Squamous Cell Carcinoma 67 Hepatitis C Genotype 67 Chronic Lymphocytic Leukemia 67 REMINDER ORLive Presents 67 #:#-# [007] 67 Chemotherapy Induced 67 Comorbid 67 Clinical Practice Guidelines 67 recurrent glioblastoma multiforme 67 Causes Symptoms 67 Antidepressants Linked 67 Guidelines Issued 66 undergoing elective percutaneous 66 Alternative Treatments 66 Receives Orphan Drug Designation 66 Carotid 66 Renal Cancer 66 Solid Tumors 66 Breast Carcinoma 66 Orthop Surg 66 Gene Mutation Linked 66 Lung Injury 66 uricase 66 PEGINTRON TM 66 Hemolysis 66 First Patient Dosed 66 Contrast Agent 66 number NCT# ClinicalTrials.gov 66 Tigecycline 66 Watchful Waiting 66 Physician Insights 66 Fibromyalgia Pain 66 Lung Cancer Trial 66 Insulin Therapy 66 Respiratory Distress 66 Mg Uk 66 Artery Disease 66 Image Guided 66 Cholesterol Lowering Drug 66 Statistically Significant 66 Ischemia 66 BERKELEY CA UroToday.com 66 patients undergoing percutaneous 66 Chronic Rhinosinusitis 66 Tocilizumab 66 Double Blind Placebo 66 Granted Orphan Drug 66 Sapacitabine 66 Hematological 66 Rare Genetic 66 psoriatic arthritis PsA 66 Patient Registry 66 Postherpetic Neuralgia 66 Critical Limb Ischemia 66 Percutaneous Tibial Nerve Stimulation 66 polyarticular 66 Corneal Transplant 66 Organ Rejection 66 Dupuytren Contracture 66 PEGylated anti 66 Candesartan 66 Preclinical Study 66 Rotavirus Vaccine 66 Well Tolerated 66 Diabetic Kidney Disease 66 venlafaxine Effexor 66 Achieves Primary Endpoint 66 Am J Clin 66 B Cell Lymphoma 66 Metastases 66 Contraindications 66 Neuroprotection 66 Antidepressant Use 66 STRIDE PD 66 undergoing Percutaneous Coronary 66 CYT# potent vascular disrupting 66 Sustained Reduction 66 BENICAR HCT 66 Reduced Risk 66 Lumbar Spine 66 Aggressive Reduction 66 diabetes mellitus DM 66 Endocarditis 66 Total Hip Replacement 66 Antiplatelet Therapy 66 Bladder Cancer 66 purpura ITP 66 candesartan cilexetil 66 Implantable Device 66 Acute Liver Failure 66 Coronary Disease 66 Bosentan 66 Peginterferon 66 Endarterectomy 66 Ann Emerg Med 66 Randomized Clinical Trials 66 Generalized Anxiety Disorder GAD 66 Eur J 66 Degarelix 66 Seasonal Allergic Rhinitis 66 juvenile idiopathic arthritis 66 Reperfusion Injury 66 Endovascular System 66 Psychiatric Services #:#-#,# 66 Patient Enrollment 66 J Clin 66 Carotid Endarterectomy 66 Myoblast 66 Rheumatoid 66 aripiprazole Abilify 66 Therapy Reduces 66 Iron Deficiency 66 Tumor Progression 66 Exacerbation 66 See CONTRAINDICATIONS 66 Acute Treatment 66 Menopausal Symptoms 66 Pivotal Phase 66 Renal Failure 66 Cardiovascular Risk 66 Stable Angina 66 Decitabine 66 Congenital Heart Disease 66 Antithrombotic 66 Metabolic Endocrinology 66 Antipsychotic 66 Insulin Delivery 66 J Pediatr 66 erythematosus 66 Epilepsy Drug 66 Treatment Experienced 66 Interferon Alfa 66 postoperative AF 66 Antipsychotic Medications 66 ACE Inhibitor 66 Peripheral Artery Disease 66 J Shoulder Elbow 66 Kidney Transplant Recipients 66 Clot Busting 66 Arch Neurol 66 Diabetic Foot Ulcers 66 Thrombolysis 66 Molecular Basis 66 Hypertrophy 66 Immune Responses 66 Hyperuricemia 66 Pulmonary Hypertension 66 Coronary Artery Bypass Grafting 66 Cardiovascular Risk Factors 66 Ovarian Cancer Patients 66 AVAPRO 66 neurogenic bladder 66 Diagnostic Criteria 66 Acute Myocardial 66 Autoantibodies 66 Test Detects 66 alfuzosin 66 Hsp# Inhibitor 66 Bloodstream Infections 66 Prospective Cohort Study 66 Unstable angina 66 Cardiac Rhythm 66 SPRYCEL ® 66 Clinical Trial Data 66 heparin induced thrombocytopenia 66 #:#-# [023] 66 J Allergy Clin 66 IND Application 66 Cardiovascular Disease Risk 66 Embolization 66 Autoimmune Disorders 66 Topical Treatment 66 Hemorrhagic Stroke 66 invasive candidiasis 66 Stenting 66 either acutely decompensated 66 Allogeneic 66 TO AVOID PREGNANCY WHILE 66 Thrombus 66 Advanced Ovarian Cancer 66 Successfully Treated 66 Significantly Improved 66 #:#-# [024] 66 Aortic Stenosis 66 Aortic Aneurysm 66 Bare Metal Stents 66 Mylan Receives Approval 66 unstable angina UA 66 Warfarin Coumadin 66 constipation OIC 66 Carotid Revascularization Endarterectomy vs. 66 Observational Study 66 Microplasmin 66 Arch Intern Med 66 Kidney Transplants 66 Rectal Cancer 66 Migraine Headache 66 #:#-# [031] 66 Coronary Artery 66 R lenalidomide 66 Afib 66 Abciximab 66 Trandolapril 66 Anticoagulants 66 Survival Rates 66 Immunosuppression 66 Successfully Completes Phase 66 ThermoDox R 66 Early Diagnosis 66 Malignant Glioma 66 Novel Mechanism 66 Paclitaxel Eluting 66 Adult Stem Cell Therapy 66 HCV Protease Inhibitor 66 #:#-#,# CrossRef Medline [002] 66 Respiratory Virus 66 Expanded Indication 66 Nonspecific 66 Adalimumab 66 Neoadjuvant 66 Renal Anemia 66 Chemotherapy induced 66 Epileptic Seizures 66 Enzyme Replacement Therapy 66 somatostatin analog 66 Golimumab 66 Stress Incontinence 66 Peginterferon Alfa 2a 66 Neurodegenerative 66 Increases Risk 66 Gene Variants 66 primidone 66 familial amyloidotic polyneuropathy FAP 66 Glycemia 66 Treatment Naïve 66 Humanized Anti 66 Sinus Infections 66 LYSTEDA 66 Clin J 66 Decompensated 66 Proc Am Soc 66 Eculizumab 66 Peripheral Arterial Disease 66 vitreoretinal disorders 66 Lung Cancers 66 Paroxysmal Nocturnal Hemoglobinuria 66 Bone Mineral Density 66 Percutaneous Coronary Intervention 66 headache abdominal pain 66 Score TOS 66 Files IND 66 Systemic Lupus Erythematosus 66 Microalbuminuria 66 Outpatient Setting 66 Trigeminal Neuralgia 66 cinacalcet 66 Therapeutic Effects 66 hypereosinophilic syndrome 66 FDA Accepts 66 Stem Cell Transplants 66 Nicotine Vaccine 66 Reflux Disease 66 Vertebral Fractures 66 Beneficial Effects 66 Known hypersensitivity 66 lexidronam injection 66 metastatic neuroendocrine tumors 66 Antihypertensive 66 Drug Resistant 66 Angina pectoris 66 Elagolix 66 ANCA associated 66 LHON 66 Newly Diagnosed Breast Cancer 66 Vertebral Compression Fractures 66 #:#-# [025] 66 chronic myocardial ischemia 66 Metabolic Efficiency 66 Aliskiren 66 CABG Surgery 66 Dose Escalation 66 Chronic Lung 66 ATACAND 66 Obese Teens 65 Gastroesophageal Reflux Disease 65 FDA Approves Drug 65 Rheumatoid Arthritis Drug 65 Carbamazepine 65 Electrical Stimulation 65 Genes Associated 65 Acute Coronary Syndrome 65 allogeneic hematopoietic stem cell 65 Transdermal Delivery 65 Eye Diseases 65 ACTEMRA TM 65 Cell Lymphoma 65 Esophageal Cancer 65 Skin Structure Infections 65 EFFEXOR XR 65 Initiates Clinical 65 Dilated Cardiomyopathy 65 Carboplatin Paclitaxel 65 Cardiometabolic 65 Interventional Procedures 65 Int J 65 Severe Primary IGFD 65 Renal Cell Carcinoma RCC 65 Anticoagulant 65 STRATEGY FOR AN OPEN 65 Menopausal Women 65 Advanced Colorectal Cancer 65 Demonstrate Significant 65 Estrogen Therapy 65 Platelet Inhibition 65 Left Ventricular Dysfunction 65 Related Mortality 65 Inhaled Steroids 65 Disease Modifying 65 Drug Combo 65 conivaptan 65 oral antidiabetic medication 65 Intracranial 65 Vaginal Gel 65 Glycemic Control 65 kidney urologic 65 Sirolimus Eluting Stent 65 hyperplasia BPH 65 Dendritic Cells 65 Glucocorticoid 65 Sinus Surgery 65 Pegylated Interferon 65 Maven Semantic 65 Who Underwent 65 Pemphigus 65 atherosclerotic renal artery stenosis 65 By JENNIFER LEARN 65 Diabetes Mellitus 65 Radical Prostatectomy 65 Accelerated Partial Breast Irradiation 65 Novel Compound 65 Diabetic Retinopathy 65 Female Urology 65 pediatric Crohn disease 65 Hypotension 65 Genetic Variant 65 transcranial Doppler ultrasound 65 Treat Heart Failure 65 HIV HCV coinfected 65 Hematopoietic Stem Cell Transplantation 65 systemic juvenile idiopathic 65 Epidermal Growth Factor Receptor 65 Demonstrated Significant 65 PICSO ® 65 Placebo Controlled Trial 65 Injection Site 65 Antitumor 65 arthritis PsA 65 Therapy Evaluation 65 Intervention Trial 65 Fewer Side Effects 65 biliary tract cancer 65 Melphalan 65 Simulect 65 Hepatic Encephalopathy 65 Patellofemoral 65 First Patient Enrolled 65 Bone Marrow Transplants 65 Hematologic 65 Hepatitis C Treatment 65 Screening Mammography 65 CIMZIA TM certolizumab pegol 65 Significantly Improves 65 preserved ejection fraction 65 Telithromycin 65 icatibant 65 Endovascular Treatment 65 Acute Attacks 65 hemodynamically significant 65 Sustained Efficacy 65 FASEB J. 65 subependymal giant cell 65 treat benign prostatic 65 unstable angina pectoris 65 Parathyroid 65 J Nutr 65 Virus Infection 65 GI motility disorders 65 Dyslipidemia 65 Exp Clin 65 Malformations 65 Exacerbations 65 Mitomycin C 65 Drug Eluting 65 Periodontal Disease 65 Investigational Drug 65 Anticancer Drugs 65 Thyroid Hormone 65 Immunologic 65 nortriptyline Pamelor 65 pregabalin Lyrica 65 Fixed Dose 65 lipid elevations 65 Kidney Failure 65 unresectable tumors 65 Partial Onset Seizures 65 Potentially Fatal 65 Angioedema 65 prospective multicentre 65 Intervention Effectiveness 65 Iron Deficiency Anemia 65 Posaconazole 65 Nephropathy 65 Demonstrates Potential 65 Preterm Infants 65 Dialysis Patients 65 NDA Submission 65 Hyperphosphatemia 65 osteoporotic vertebral fractures 65 Liver Metastases 65 Physical Function 65 Robotic Assisted 65 Antibiotic Resistant 65 FULL PRESCRIBING INFORMATION 65 Chronic Wounds 65 Virtual Colonoscopy 65 Hodgkin lymphoma HL 65 Recurrent Glioblastoma 65 patientswith 65 Metabolic Disease 65 invasive aspergillosis 65 Vitamin D Linked 65 J Antimicrob Chemother 65 IN PATIENTS WITH 65 Multicenter Trial